z-logo
Premium
Rh D/d genotyping by quantitative polymerase chain reaction and capillary zone electrophoresis
Author(s) -
Cossu Gianfranco,
Angius Antonia,
Gelfi Cecilia,
Righetti Pier Giorgio
Publication year - 1996
Publication title -
electrophoresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 158
eISSN - 1522-2683
pISSN - 0173-0835
DOI - 10.1002/elps.1150171217
Subject(s) - capillary electrophoresis , genotyping , polymerase chain reaction , chromatography , polymerase chain reaction optimization , chemistry , electrophoresis , microbiology and biotechnology , nested polymerase chain reaction , biology , genotype , biochemistry , gene
Abstract A safe and reliable method for determining RhD type (positive or negative) and zygosity (D/D or D/d) could have applications, for instance, in the prediction of the D genotype of a father in couples where there is an RhD‐negative woman at risk of fetal alloimmunization. Capillary zone electrophoresis (CZE) is proposed as a novel, reliable and powerful method for quantitative evaluation of polymerase chain reaction (PCR) products. RhD is determined by amplifying a 136 bp region common to the RhCcEe and RhD genes and a 186 bp region specific of the RhD gene. RhD positive and negative samples are identified by polyacrylamide gel slab electrophoresis, followed by silver staining of the DNA bands, and by CZE in sieving liquid polymers, with direct on‐line peak densitometric evaluation by exploiting the intrinsic UV absorbance of the DNA fragments at 254 nm. The CZE method allows not only a reliable assessment of the RhD type (the presence of both 136 bp and 186 bp fragments indicating an RhD‐positive type, the presence of only the 136 bp fragment indicating an RhD‐negative type), but also a rapid determination of the zygosity based on the quantitative expression ratio of the 136 bp/186 bp pair. Thus, a 2:1 peak ratio clearly indicates a D/D homozygous individual, whereas a 3:1 peak ratio gives evidence of a D/d heterozygous individual.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here